Royal National Orthopaedic Hospital NHS Trust Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03463642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Royal National Orthopaedic Hospital NHS Trust

Active Ingredients

Drugs in Phase 2 Trials (1)

saracatinib (1 trial)

Drugs in Other Trials (4)

orange (1 trial)

paraffin oil (1 trial)

tangerine peel (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Myositis Ossificans (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5